Innate Pharma S.A. (LON:0EVI)
London · Delayed Price · Currency is GBP · Price in EUR 1.520
-0.046 (-2.94%)
At close: Jan 13, 2026
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of 120.31 million as of January 16, 2026. Its market cap has decreased by -5.59% in one year.
Market Cap
120.31M
Enterprise Value
91.71M
Revenue
10.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.52
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 530.53K to 120.31M, an increase of 22,577.58%. That is a compound annual growth rate of 32.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 120.31M | -6.61% |
| Dec 31, 2025 | 128.82M | -2.60% |
| Dec 31, 2024 | 132.26M | -27.85% |
| Dec 29, 2023 | 183.31M | -21.67% |
| Dec 30, 2022 | 234.02M | -20.77% |
| Dec 31, 2021 | 295.36M | 20.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 222.49B |
| HSBC Holdings | 207.99B |
| Shell | 156.28B |
| Unilever | 106.98B |
| Rio Tinto Group | 106.77B |
| Rolls-Royce Holdings | 106.64B |
| British American Tobacco p.l.c. | 92.08B |
| GSK plc | 75.45B |